STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

KMDA KAMADA LIMITED StockScouter® Report

7

StockScouter® Score

KAMADA LIMITED, a small cap growth company in the healthcare sector, is expected to outperform the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive
  • The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive

 

Concerns

  • Short-term relative price momentum exhibits meaningful weakness. Negative
  • Shares are being sold by financial institutions. Slightly negative for a small company like KMDA

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 40% done.
Progress: 100% done.
Low
High

Core Model Grades

A
C
C
C

Previous Ratings

8
9
10